Pantai Premier Pathology (PPP) celebrated its 25th anniversary on 21 December 2022, with an appreciation dinner for staff and partners attended by IHH Chairman Tan Sri Mohammed Azlan and IHH Managing Director & CEO Dr Kelvin Loh.
Additionally, PPP recently announced two new collaborations with bioMérieux and MiRXES to strengthen our lab diagnostics capabilities.
Under the MOU with French biotech MNC bioMérieux, PPP will set up an Antimicrobial Stewardship Centre of Excellence to promote the responsible use of antibiotics and preserve the efficacy of these drugs for the present and future generations. PPP plays a crucial role in supporting the efforts to contain antimicrobial resistance by identifying the pathogen responsible for a patient's infection and conducting antimicrobial susceptibility testing to determine the optimal antimicrobial therapy for the patient.
The collaboration with MiRXES seeks to provide accessible and affordable molecular oncology testing to Malaysians which includes the early detection of gastric cancer via blood test and DNA testing.
These partnerships are critical towards providing our patients with the best care and clinical outcomes. We look forward to further serving our communities through these partnerships.
Congratulations to the PPP team on its Silver Jubilee and the two MOUs!
Related Stories
Fortis Healthcare Expands Footprint with New 200-Bed Hospital in Greater Noida
See how Fortis strengthens its Delhi-NCR network and enhances access to quality care.
Fortis Manesar Breaks New Ground in Cardiac Care
Discover how a life-changing, minimally invasive procedure gave a 16-year-old patient a second chance
IHH Healthcare Debuts FutureHealth.Now Conference
See how we united visionary minds across healthcare, government and business to spark bold ideas and forge new partnerships that will push the boundaries of care at our inaugural global leadership conference.
Unveiling Our New IHH Healthcare Identity
Prince Court Medical Centre Performs Malaysia’s First Kelly Procedure
